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(From the Department of Pathology,  New York University  Medical  Center, New York 10016) 
Immune precipitates formed by bovine serum albumin (BSA) I and antibodies 
to  BSA  dissolve rapidly  when  incubated  in  fresh  serum  (1).  The  solubilized 
complexes are aggregates of antigen  (Ag), antibody (Ab), and complement (C) 
components  (C3).  The  involvement  of C  in  this  activity  of serum  (complex- 
release activity or CRA) was postulated because treatments that destroyed C in 
serum also removed CRA. The present paper further clarifies the mechanism of 
CRA.  It  will be shown that  (a)  CRA of serum is observed with many Ag-Ab 
systems and  therefore  appears  to  be a  general  phenomenon.  (b) The  rate  of 
solubilization  of complexes varies in different Ag-Ab systems and  is strongly 
influenced by the affinity of Ab for Ag in the immune precipitate.  (c) CRA is a 
function of the properdin pathway of C activation. (d) C-mediated CRA does not 
involve proteolysis of the Ab, and (e) CRA can also be achieved by the specific 
binding of a large peptide onto the Fab or Fc portions of the Ab that is part of the 
immune precipitate.  Based on these results we propose that CRA is caused by 
the intercalation  of C fragments (C3b, C4b) into the lattice formed by Ag and 
Ab. 
Materials  and  Methods 
Diluents.  CRA  assays  were  carried  out  in  phosphate-buffered  saline  (PBS,  Grand  Island 
Biological Co., Grand Island, N. Y.), pH 7.4, which contains Ca ++ (7 ×  10 -4 M) and Mg ++ (5  x  10 -4 
M). 
Antigens  and  Antibodies.  Pneumococcal  polysaccharide  type  VII (S  VII)  was  obtained  as 
described by Tyler and Heidelberger (2) and was a  gift from Dr. M.  Heidelberger. Dextran was 
kindly supplied by Dr.  M.  Leon.  Ovomucoid (OVM) and ovalbumin (OA) were purchased  from 
Sigma Chemical Co., St.  Louis, Mo.  Bovine gamma globulin (BGG) and bovine serum albumin 
(BSA, 2  x  crystallized) were purchased  from Pentex Inc.,  Kankakee,  Ill. BSA was purified on 
Sephadex G-200 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) to remove aggregates. BSA 
and BGG were conjugated with 2,4-dinitrophenol (DNP), as described in (3) by reaction of 1-fluoro- 
2,4-dinitrobenzene and dioxane under alkaline conditions, followed by extensive dialysis. Protein 
concentrations were determined by Kjeldahl analysis,  and the degree of substitution  was calcu- 
lated by absorbancy at 360 nm. DNP-BSA and DNP-BGG had 32 and 57 DNP tool per tool of carrier 
protein. Normal rabbit immunoglobulin (IgG) was purchased from Miles Laboratories, Kankakee, 
Ill. and further purified on a DEAE-cellulose column. Normal sheep IgG and guinea pig IgG (72) 
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Abbreviations  used in this paper:  BGG, bovine gamma globulin; BSA, bovine serum albumin; 
CFA, complete Freund's adjuvant;  CRA, complex release activity; DNP, 2,4-dinitrophenol;  OA, 
ovalbumin; OVM, ovomucoid; PBS, phosphate-buffered saline; SDS, sodium dodecyl sulfate. 
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were  prepared  by  passage  through  DEAE-cellulose  columns after  precipitation  from  serum in  40% 
(NH4)2SO4. Purified  mouse myeloma protein  (MOPC  104E) of  the IgM class,  with specificity  for 
dextran, was purchased from Litton  Bionetics,  Inc.,  Kensington, Md. A globulin  fraction  from a 
rabbit  antiserum to pneumococcus S VII was given to us by Dr. M. Heidelberger. Antibodies to 
OVM  were raised  in CBA/J mice (The Jackson Laboratories,  Bar Harbor, Maine) by injection  of 
250/~g of  OVM  in complete Freund's adjuvant (CFA, Difco  Laboratories,  Detroit,  Mich.) into  the 
foot  pads (total  volume injected  0.10  ml) and bleeding  4 wk later.  Mouse and rabbit  antibodies  to 
BSA and rabbit  antisera  to  mouse Ig  were obtained  as previously  described  (1,  4).  Rabbit  antisera 
to  F(ab')~  fragments  of  guinea  pig  IgG (,/2)  and to  DNP-BGG  were obtained by injection  of  i  mg of 
purified  protein  emulsified  in  CFA into  the  footpads  (total  volume injected  I  ml) and  bleeding 2-12 
wk later.  Sheep antiserum against  the Fab  fragment  of  rabbit  IgG  was obtained by Dr. M. Lamm 
by  injection  of  purified  Fab  (5)  emulsified  in  CFA. Sheep  antiserum  to  rabbit  IgG  containing a high 
concentration  of  antibodies  to  the Fc  portion  of  the  rabbit  IgG  was  a gift  from  Dr. G. J.  Thorbecke. 
It was extensively  adsorbed with F(ab')2  fragments of  rabbit Ig conjugated to Sepharose beads 
activated  with CNBr (6).  Ig  fractions  of  both sheep  antisera  (anti-Fab,  anti-Fc)  were prepared as 
described  above, and their  specificities  were verified  by immunoelectrophoresis  against a papain 
digest  of  rabbit  IgG. In addition  the sheep antirabbit  Fab gave a reaction  of  identity  by double 
diffusion  in  agar  gels  between  rabbit  F(ab')2  of  IgG  and  native  IgG. The  sheep  antirabbit  Fc  did  not 
precipitate  rabbit F(ab')2  in liquid  or gelified  media. The antibody concentration of  all antisera 
was determined by quantitative  precipitation  (7)  as described  in (8). 
Preparation ofFab, Fab', and F(ab')2  Fab fragments of  normal or immune sheep Ig and of 
rabbit  IgG were obtained as  in  reference  9, except  that  after  digestion  with  papain  the fragments 
were separated from  undigested material by  chromatography on Sephadex G-200  columns. F(ab')~ 
fragments were also  prepared as in reference  9. Fab' fragments of  rabbit  antibodies  to mouse Ig 
were prepared by  reduction of F(ab')~  with mercaptoethylamine hydrochloride (9) and further 
purified  by chromatography on Sephadex G-100 columns. Two protein  peaks were eluted,  one 
containing Fab' and the other nonreduced F(ab')2. 
Determination  of the Binding Affinity (Ko) of Rabbit Anti-DNP Antibodies.  Sera were ob- 
tained 2 wk and 12 wk after the immunization of rabbits with DNP-BGG. The IgG fractions were 
prepared, and the concentration of antibodies to DNP was determined by specific precipitation 
with DNP-BSA. Affinities (Ko) were estimated by the method of Stupp et al. (10) with [aH]DNP-~- 
aminocaproic acid (synthesized by Dr. J. Quagliata) as hapten. 
Iodination  of Proteins.  Antibodies and protein antigens were iodinated by the chloramine T 
method (11), as described in reference 12. The specific activity of labeled proteins was about 2 × 10" 
cpm/~g. Labeled proteins were frozen at -20°C and used within 5 wk. 
Complement  Components  and  C-Deficient  Sera.  Human  C2,  C3,  and  guinea  pig  C4  were 
bought from Cordis Laboratories, Miami, Fla. Factor B of the properdin pathway, prepared as in 
reference 13,  was  a  gift  from  Dr.  O.  G6tze  and  it  showed a  single band  by  acrylamide  gel 
electrophoresis. Human C2- and C3-deficient sera were gifts from Dr. N. K. Day, and C4-deficient 
guinea pigs were obtained from Dr. M. Frank. Sera to be used as a source of C were kept at -70°C. 
Assay for CRA.  Based on data from quantitative precipitation curves, immune precipitates 
were prepared at different Ag-Ab ratios with 125I-labeled antigen or ~s'~I-labeled  IgG fraction of the 
specific antiserum, washed with PBS, resuspended in PBS, and finely divided by passage through 
a 27-gauge needle. Immediately before incubation at 37°C, the precipitates were added to reaction 
mixtures containing serum diluted with PBS. The final vol of  the mixtures varied from 200-400  ~l. 
Samples (50  /~l) were withdrawn at certain time intervals and placed in 10  ×  75-mm test tubes 
which contained between 0.25-1 ml of an ice-cold suspension of 0.05% sheep erythrocytes in 0.15 
M NaCl (the erythrocytes were added as a marker to facilitate decantation). After centrifugation 
at 1200 g at 4°C for 10 min, the tubes were decanted, and both pellets and supernatant fluids were 
counted in a  gamma counter. Results were generally expressed as percent solubilization (100  x 
cpm  in  supernatant fluids/total cpm).  Controls consisted of the  same complexes incubated in 
serum pretreated with zymosan (1) or serum heated at 56°C for 30 min. 
For the solubilization of immune precipitates by Fab fragments, the same general procedure 
was used, except that the reaction mixture (150 ~l) contained Fab fragments instead of serum, 2 × 
10 -3  M  recrystallized iodoacetamide (Schwarz/Mann,  Orangeburg,  N.  Y.),  and  0.5  mg OA  to 
reduce nonspecific binding of proteins to the glass tube. JOYC~  czoP  AND  VICTOR  NUSSENZW~.m 
TABLE I 
A ntigen-Antibody Complexes Solubilized by Serum 
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Antigen  Species of origin of antibody 
BSA  Rabbit, mouse (7S) 
Pneumococcal S VII  Rabbit (7S) 
OVM  Mouse (7S) 
Guinea pig F(ab')2 of IgG~  Rabbit (7S) 
Dextran  Mouse (MOPC-104E) (19S) 
DNP-BSA  Rabbit (7S) 
Immune precipitates  were  prepared  in  Ab excess,  at equivalence,  and  in Ag  excess.  Various 
amounts of these precipitates were treated with serum. In each case, CRA was detected. The rates 
of s01ubilization, however,  were considerably different. For example,  150  ftl fresh rabbit serum 
solubilized 5.2 pg of an immune precipitate containing anti-S VII and S VII within 4 min and 0.75 
~g  of  an  immune  precipitate  containing  anti-DNP  and  DNP-BSA  only  after  50  min.  Both 
precipitates were prepared at equivalence. 
Acrylamide Gel Electrophoresis.  Samples of solubilized products were either treated with 1% 
sodium dodecyl sulfate (SDS) for 1 h at 60°C or denatured and reduced by incubation in 1% SDS, 5% 
2-mercaptoethanol, and 0.5 M urea in 0.1 M Tris buffer, pH 8.3, for 1 h at 60°C.  Analysis of these 
samples by acrylamide gel electrophoresis was as described by Shapiro et al. (14),  except that the 
gels were removed from the glass tubes, frozen with dry ice, and cut into 1-mm fractions with a 
Mickle slicer. The radioactivity in each fraction and in the uncut end of the gel were counted on a 
gamma counter. 
Results 
Solubilization of Ag-Ab Complexes by Serum (CRA) is a General Phenome- 
non.  CRA was initially observed with immune precipitates of BSA and mouse 
or rabbit anti-BSA (1). Listed in Table I are other immune precipitates which 
are solubilized by serum. This serum and the antibody in the immune precipi- 
tate do not have to originate from the same species of animal. Specific precipi- 
tates,  prepared  with  mouse  antibodies to  BSA  and  BSA,  are  solubilized  at 
different rates by pooled serum from different species. In general, we found that 
CRA of rat >  human >  mouse >  guinea pig >  rabbit serum with precipitates 
prepared with mouse antibodies. 
Effect of the Affinity of Antibody on CRA.  Although solubilization occurred 
in all Ag-Ab systems tested, its rate varied considerably even when the same 
source of C was used. For example, in rabbit serum, precipitates of rabbit anti-S 
VII and S VII are more rapidly solubilized than identical amounts of  rabbit anti- 
BSA and BSA. Furthermore, for a given amount of serum, there is a maximum 
quantity of immune precipitate which can be solubilized, and this varies for 
different Ag-Ab systems. We calculated that the maximum amount of precipi- 
tate that can be  solubilized by 0.4  ml of a  one-half dilution of rabbit  serum 
contains about 1.8 ~g rabbit (IgG) anti-BSA. Under the same conditions, more 
than 50 ~g rabbit (IgG) anti-S VII can be released from immune precipitates. 
One of the parameters that affects and may explain these differences is the 
affinity of the Ab for the Ag in the precipitate. In Fig. 1 we compare CRA among 
complexes  prepared  with  anti-DNP  antibodies of different affinities for the 618 
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Effect  of affinity  of antibody  on CRA.  Immune  precipitates  prepared  at various  Ab/ 
Ag ratios were prepared with ~25I-labeled  DNP-BSA and purified rabbit IgG fractions that 
contained  either  high  (Ko  =  108  liters/mol)  or  low  (Ko  =  2  ×  107  liters/mol)  affinity 
antibodies to DNP. Aliquots containing 0.6 ~g ofcomplexed Ab were incubated at 37°C with 
human serum (100 fd) in a total volume of 300  ~l. 
hapten and show that rates of solubilization are considerably higher for the anti- 
bodies of lower affinity at all Ag-Ab ratios tested. 
Solubilization is C Mediated.  The involvement of C in the process of solubi- 
lization  was previously suggested  because CRA was inhibited  at  0°C,  in  the 
presence of chelating agents, and by pretreatment of the serum with zymosan or 
cobra venom factor (1).  Direct evidence for the participation  of C  is shown in 
Figs. 2-4. CRA of human serum is destroyed at 50°C for 20 min.  Total restora- 
tion  of activity is achieved by the  addition  of physiological concentrations  of 
purified factor B (Fig.  2). 
Also, CRA was studied in a human serum lacking C3, but containing close to 
normal concentrations of all other C components of the classical pathway (15). It 
failed to solubilize immune precipitates even when undiluted, although normal 
human serum rapidly solubilized the same complexes when diluted one-twen- 
tieth.  The  addition  of purified  human  C3  to  the  deficient  serum  partially 619 
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FIG. 2.  Solubilization  is dependent on factor  B. In a reaction mixture of 200 /zl,  fresh 
human serum (50  ~l),  which  had been  heated  at  50°C for  20  rain,  failed  to  solubilize  0.35  ~g 
immune precipitates  prepared at equivalence with rabbit  ~SI-labeled  anti-BSA and BSA. 
After supplementation with 15 ~g purified  human factor  B, the rate  of  solubilization  was 
nearly  the same as  that  of  the  tube  containing  unheated  serum. Purified  factor  B (15/~g),  by 
itself,  failed  to solubilize  complexes. 
restored CRA and the rate of  solubilization was dependent on the quantity of C3 
added. Human C3, in the absence of serum, failed to solubilize these complexes 
at all concentrations tested (Fig. 3). 
Involvement of the classical pathway of C activation in the release process 
was demonstrated by the addition of purified C2 to the serum of a patient who 
was homozygous for C2 deficiency (Fig. 4) or of C4 to the sera of C4-deficient 
guinea pigs  (not  shown).  Although CRA was  detected in the  deficient sera, 
addition of the missing C components led to enhanced CRA in each instance. 
Solubilization  Does Not Involve Extensive Proteolysis of Ab in the Precipi- 100 
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FIG, 3.  CRA  is dependent on the concentration of C3. Human  C3-deficient  serum (15) 
failed  to solubilize  immune precipitates  at all  dilutions  tested  unless C3 was added to the 
reaction mixtures (final  vol 200 /~l)  which contained: 0.05  #g J~'~I-labeled  rabbit anti-BSA 
precipitated with BSA in Ab excess, normal or C3-deficient  human serum, and various 
amounts of  C3 (i,000  CH~ U/ml). C3 alone at  all  concentrations or  heated human serum did 
not solubilize  immune precipitates. 
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FIG. 4.  Solubilization  is  enhanced by C2, Human  C2-deficient  serum solubilized  immune 
precipitates  in reaction  mixtures (final  volume 200 ~I) which contained 2.8 #g rabbit  anti- 
BSA complexed with '3'I-labeled  BSA  in Ag excess. Solubilization was enhanced when 
human C2 (75 CH.~o  U) was added, Solubilization  did not occur in normal or C2-deficient 
human serum heated at  56°C for  30 rain  and supplemented with different  amounts of  C2. 
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tates.  One explanatioh for the phenomenon of solubilization is that proteolytic 
activity is generated during C activation leading either to the fragmentation of 
the Ab and formation of nonprecipitating  monovalent Fab-like fragments or to 
the alteration  of the combining site.  By acrylamide gel electrophoresis,  how- 
ever, we did not detect fragments of Ab among the solubilized products which 
had been treated with sodium dodecyl sulfate (Fig. 5 a), but did consistently find 
labeled material  of high molecular weight in such preparations and not in the 
controls.  This  material  is probably aggregated  Ab and/or  Ab molecules com- 
plexed with C components.  It is unlikely that this material  of high  molecular 
weight is fragmented Ab which became aggregated under the conditions used to 
dissociate Ag from Ab, because after complete reduction and alkylation of the 
solubilized Ab, no fragments of labeled H or L chains were detected by acrylam- 
ide gel electrophoresis (Fig.  5 b). 
Additional evidence against the hypothesis that a simple enzymatic reaction 
determines the solubilization of complexes is shown in Fig. 6. Various amounts 
of immune precipitate were added to a  constant volume of a  dilution of rabbit 
serum, and the rates of solubilization were determined.  After subtracting back- 
grounds,  we calculated the absolute amounts of antibody that were solubilized 
in the presence of excess immune precipitate  after different periods of incuba- 
tion.  In  several  runs  we  found  that  the  maximum  amounts  of solubilized 
complexes generated by a  constant  amount of serum were independent of the 
initial  concentrations  of immune precipitate.  For example,  in the experiment 
shown, 2.8,  5.6, and  11.2  ~g of BSA-precipitated rabbit antibody to BSA were 
incubated at 37°C with 400  ~l of a  one-half dilution of rabbit serum.  After the 
reaction reached  completion,  about 61,  32,  and  13% of the antibody had been 
released, that is 1.7,  1.8,  and 1.5  ~g, respectively. Furthermore,  the amount of 
released  antibody  did  not  increase  by prolonging  incubation  at  37°C.  These 
results are compatible with solubilization  as a  result of a  stoichiometric reac- 
tion,  not an enzymatic degradation. 
Immune  Precipitates  are  Solubilized  by  Specific  Fab  Fragments.  It  was 
previously  reported  (1)  that  Fab  fragments  of rabbit  antimouse  Ig  rapidly 
solubilized immune precipitates of BSA and mouse anti-BSA. This implies that 
the binding of a large peptide to Ig molecules is sufficient to disrupt the Ag-Ab 
lattice, thus increasing the solubility of the immune complexes. This finding led 
to the hypothesis that solubilization of immune precipitates by C might occur by 
a similar process. In this case, fragments of C components, such as C3b, would 
intercalate  into the lattice. 
We show here that (a) a  large peptide that is believed to intercalate into the 
lattice must be monovalent for solubilization of immune precipitates to occur. 
This was clearly shown when the effects of Fab' and F(ab')2 on immune precipi- 
tates  were compared.  Various  amounts  of Fab',  and  F(ab')2 were mixed with 
washed precipitates of mouse antibodies to BSA (2 ~g) and 12~I-BSA, incubated 
at  37°C  for  30  min,  and  centrifuged.  Fab'  and  Fab  solubilized  the  immune 
precipitates with almost the same efficiency (Table II). Not only did F(ab')2 fail 
to solubilize the immune precipitates, but it decreased their solubility to levels 
below that of the controls. 622  SOLUBILIZATION OF  IMMUNE  PRECIPITATES  BY  SERUM 
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FIG.  5.  Analysis  of solubilized  products by polyacrylamide  gel electrophoresis.  (a) 100 ~1 of 
a suspension of an immune precipitate prepared in antibody excess and containing  0.56/~g 
of '25I-labeled rabbit anti-BSA and BSA was incubated with 200 ~l fresh or heated (56°C, 30 
min) human serum. After incubation  for 60 min at 37°C the tubes were centrifuged and the 
supernatant fluids collected. 80 and 20% of the labeled antibody were found in the superna- 
tant fluid containing  fresh and heated human serum, respectively. The supernatant fluids 
were  treated  with  SDS,  as  described  in the  Methods  section,  and electrophoresed  in 
acrylamide gel. 85% of the loaded counts were recovered.  (b) Supernatant fluids containing 
released and nonreleased immune complexes were obtained as described in (a). Antibody in 
the supernatant fluids was completely reduced in the presence of urea and mercaptoethanol 
to separate H and L chains and electrophoresed  in acrylamide gel. 85% of the loaded counts 
were recovered.  Negligible counts were found after fraction 80. 
(b)  The  peptide  that  intercalates  into  the  lattice  can  solubilize  immune 
precipitates by binding either  to  the  Fab or  the  Fc  portions of the  Ig  in the 
precipitates.  As shown in Fig.  7,  a  precipitate of rabbit anti-S VII and S  VII 
can be solubilized by Fab of sheep antirabbit Fab or Fc. About 3/~g of either type 110C 
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of specific Fab were required to solubilize about 50% of the precipitates contain- 
ing 0.6/~g antibody. This is a ratio of about 15 molecules of Fab per molecule of 
Ab. The specificity of the Fab reagents is demonstrated in Fig. 8. Normal rabbit 
IgG inhibited solubilization by the Fab fragments of both anti-Fab and anti-Fc, 
but F(ab')2 fragments of nonspecific rabbit IgG inhibited only the solubilization 
by Fab anti-Fab. 
Discussion 
We show here that  solubilization  of Ag-Ab aggregates  by fresh serum is a 
general phenomenon mediated by the C cascade. The species of origin of the Ab 
in the complexes and of the serum used as a source of C can be different. Ag-Ab 
complexes prepared  with  rabbit  or  mouse Ab are  solubilized  by mouse,  rat, 
rabbit, guinea pig, or human C, which suggests that both the C activation sites 
and  the  targets  of the  reaction  within  the  complexes may be similar  among 80 
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mediated CRA.  Various concentrations of immune  precipitates  consisting of ~251-1abeled 
3b 
rabbit  anti-BSA and BSA at  equivalence were treated  with 200 ~l fresh  or  heated (56°C for 
30 min) rabbit serum in a reaction mixture of  400 pl. After incubation at 37°C, samples (50 
/A) were withdrawn at intervals,  placed in tubes (10 x 75 ram) that contained 0.25  ml ice- 
cold 0.05% SRBC,  and centrifuged. Note that although the rates  of solubilization are 
different,  the maximum  amount of  precipitate  that  can  be  solubilized  by 200 #l  rabbit  serum 
under these conditions  contains about 1.7 pg of  Ab. 
TABLE  II 
Solubilization of Immune Precipitates of '2'~I-BSA and Mouse 
Anti-BSA by Fragments of Rabbit Antibodies to Mouse Ig 
Nature of fragments  Amount of specific 
of rabbit antimouse 
Ig  fragment 
Fab 
Solubilization 
p~  % 
1.0  10.1 
2.5  45.5 
5.0  90.4 
10.0  93.2 
Fab'  1.0  15.5 
2.5  78.4 
5.0  93.4 
10,0  93.8 
F(ab')2  1,0  2.1 
2,5  2,4 
5.0  2.3 
10,0  2.7 
Control  7.8  ±  0.9* 
* Mean ±  SD. 
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Fro.  7.  Solubilization  of immune precipitates by specific  Fab fragments.  (a)  Immune 
precipitates, containing 0.6 pg (4 × 10 -'2 tool) rabbit anti-S VII (labeled with 125I) and S VII 
at equivalence,  were treated with various concentrations  of Fab fragments of sheep IgG, 
sheep antirabbit Fab, or sheep antirabbit Fc in the presence of 2 x  10  -3 M iodoacetamide 
and 0.5 mg OA in PBS. The reaction mixtures (final vol 150 ~l) were incubated  at 25°C for 
2.5 h and diluted  with 1.0 ml 0.05% SRBC before centrifugation.  50% solubilization  was 
achieved with 3 ~g (6 x 10-" mol) of either Fab anti-Fab or Fab anti-Fc. 
different  species  and  were  well  preserved  during  evolution.  The  absolute 
amount of complexes that can be solubilized by C varies widely in different Ag- 
Ab systems. The explanation for these differences is not clear, but one factor is 
the  affinity of the  antibody  for Ag in the  precipitate.  Precipitates  made with 
antibodies to DNP of higher affinity for the hapten required a higher concentra- 
tion of C  and a  longer period of incubation at 37°C. 
Solubilization by C is mediated through the properdin pathway. It proceeds in 
the absence of Ca ++ (1), but not in the absence of Mg  +÷, C3, factor B (this paper), 
properdin,  or factor D  (Takahashi,  Brade,  and  Nussenzweig,  in  preparation). 
The enhancement of CRA by the addition of Ca ÷+ (1), or of C2 and C4 to C2- and 
C4-deficient sera can be explained by the generation of C3b through the classical 
pathway  and  its  positive feedback  effect on  the  properdin  pathway  (16),  The 
possibility,  however,  that  CRA  can  also  be  mediated  directly  through  the 
classical  pathway,  without  participation  of the  properdin  pathway,  cannot  be 
ruled out. 
The mechanism of solubilization does not appear to involve degradation of the 626  SOLUBILIZATION  OF  IMMUNE  PRECIPITATES  BY  SERUM 
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FxG. 8.  The precipitates  described above were mixed with 15 /~g (3 x  I0  -I° tool)  of  Fab 
fragments of sheep anti-rabbit  Fab or sheep anti-rabbit  Fc. Various concentrations of 
purified rabbit  IgG or purified  rabbit  F(ab')~  were added to these mixtures that were 
incubated for  2.5  h at  25°C and treated  as  described  above. Addition of  F(ab')=  inhibited  the 
activity  of  Fab anti-Fab,  but not of  Fab anti-Fc.  Both activities  were inhibited  by rabbit 
IgG. Symbols: (A  A) Fab anti-Fc (solubilizing  agent) and rabbit  F(ab')2  (inhibitor); 
(R  I) Fab anti-Fab (solubilizing  agent) and rabbit  F(ab')2  (inhibitor);  (O  O) Fab 
anti-Fc  (solubilizing  agent) and rabbit  IgG (inhibitor). 
complexed antibody. By acrylamide gel electrophoresis we failed to detect small 
molecular weight products of Ag among solubilized complexes. 
An alternative explanation for the phenomenon of solubilization is that it 
follows the incorporation of fragments of C components, such as C3b and C4b, 
into the Ag-Ab lattice. These high mol wt peptides (175,000 and 200,000, respec- 
tively) are generated by enzymatic cleavage of C3 and C4. C3b and C4b have 
labile "nonspecific" combining sites, perhaps of a hydrophobic nature, for con- 
stituents  of the  cell  membrane  and  also  for  immunoglobulin (17-19).  It  is 
generally thought that the state of activation of C3b and C4b is of extremely JOYCE  CZOP  AND  VICTOR  NUSSENZWEIG  627 
short duration and that,  consequently, activated C3b  and  C4b  bind  only to 
acceptor sites in molecules that are in close proximity. Otherwise they become 
inactive. According to the intercalation hypothesis the binding of these peptides 
on to the Ag-Ab aggregates would inhibit lattice formation and reverse precipi- 
tation. 
The main arguments to support the intercalation hypothesis are: (a) solubili- 
zation appears to be a stoichiometric reaction and not an enzymatic process. The 
maximum amount of complexes that can be solubilized by individual sera is 
independent of the initial concentration of complexes, cannot be increased by 
prolonged incubation, and correlates well with the concentration of C3 in the 
serum (Czop, J. K., A. Ferreira, and V. Nussenzweig, manuscript in prepara- 
tion); (b) C3 and C4 (Takahashi, M., and V. Nussenzweig, unpublished observa- 
tion) fragments are found on solubilized complexes (1); and (c) immune precipi- 
tates are solubilized by Fab fragments specific for the Ig in the precipitates. The 
possibility that this key finding is an artefact due to the persistence of papain 
adsorbed on the Fab fragments is very unlikely because as shown here, Fab- 
mediated CRA proceeds rapidly in the presence of 2  ×  10  -3 M iodoacetamide. 
Moreover, Fab'  fragments, but not F(ab')2 fragments of rabbit antimouse Ig, 
solubilize immune precipitates as effectively as Fab fragments. Even if pepsin 
was present and active at pH 7.4 only in the preparations of Fab'  and not in 
those  of F(ab')2,  the  resulting  product  would  be  F(ab')2  fragments and  no 
solubilization should have occurred. 
Fab and Fab' fragments solubilized complexes at ratios of about three mole- 
cules of the monovalent reagent to one molecule of antibody in the precipitate. 
However, at all concentrations, F(ab')2 decreased the solubility of the immune 
precipitates,  probably because they further cross-linked the antibody in the 
precipitate.  According to  these findings,  the binding of a  large  monovalent 
peptide onto the Fab  or Fc portions of the antibody may alter its  ability to 
precipitate in the presence of antigen. By analogy, if the intercalation hypothe- 
sis is correct, the C fragments which solubilize the complexes should be func- 
tionally monovalent. In contrast, C components such as Clq, which have multi- 
ple binding sites for Ig, should decrease the solubility of immune complexes. 
How specific Fab  anti-Ig (and perhaps  C fragments) interfere with lattice 
formation and precipitation is  not clear.  The bulky peptides  may sterically 
interfere with the primary binding of antibody to antigen, or induce conforma- 
tional changes in the combining site, or diminish the flexibility of the Fab arms 
around  the  hinge  region  and  thereby restrain  the  cross-linking of antigen 
molecules. The Fab fragments may also prevent lattice formation by inhibiting 
nonspecific Ig-Ig interactions which occur during specific  precipitation.  For 
example, Nisonoff and Pressman (20) acetylated specific antibodies to increase 
their negative charge. Antibodies, acetylated at low levels, did not precipitate 
with homologous antigens although the combining site was not affected. Appar- 
ently, the forces involved in Ag-Ab interaction were not strong enough to bring 
the Ag and the mutually repelling Ab molecules together. In contrast to acetyla- 
tion, iodination of antibodies enhances precipitation apparently by increasing 
hydrophobic interactions between neighboring antibodies (21). It is possible that 628  SOLUBILIZATION  OF  IMMUNE  PRECIPITATES  BY  SERUM 
C3  fragments  (and  perhaps  other  C  components)  incorporate  into  the  lattice 
during the release reaction and cause solubilization by similar mechanisms. 
The finding that precipitates prepared with high-affinity antibodies are more 
difficult to  solubilize  by C  activity demonstrates  that  primary  Ag-Ab bonds 
influence  the  reaction.  According to the  intercalation  hypothesis,  the  rate  of 
solubilization will depend on the relative affinities of the C peptides for the Ab in 
the precipitate and of the Ab for the Ag. An alternative and less likely explana- 
tion for the marked effect of the binding affinity of Ab on CRA is that antibodies 
of lower  affinity  interact  more  efficiently  with  C  to  generate  more  effector 
peptides (22). 
The  results  of these  experiments  may  be  relevant  to  immunopathology. 
Various biological and pathological processes are triggered by the Ag-Ab reac- 
tion, both when it occurs in the fluid phase and on the membrane of cells. It is 
likely that under normal circumstances Ag-Ab complexes which activate the C 
cascade  through  the  properdin  pathway  are  transformed  into  released  com- 
plexes  which  contain  C3  and  C4  fragments.  Since  C  affects  the  degree  of 
aggregation, solubility, and composition of complexes, released complexes could 
have different biological and pathological activity from nonreleased complexes. 
Indeed,  we  found  that  released  complexes  have  low binding  affinity for  the 
membranes of platelets and blood leukocytes (23, 24). Because Ag-Ab complexes 
(without C) mediate the release of inflammatory agents from cells, it is conceiv- 
able that the C system plays a hitherto unsuspected role in protecting the body 
from potentially  damaging complexes.  Furthermore,  according to our results, 
immune  complexes which are formed in vivo under  conditions of C  depletion 
would  have  a  greater  tendency  to  aggregate  (25).  This  may  increase  their 
tendency  to  deposit in  tissues.  If correct,  this  hypothesis  would have  conse- 
quences for the therapy of diseases in which low levels of C are observed: in some 
circumstances the enhancement of serum levels of certain C components might 
be beneficial for the patient. 
Summary 
Antigen (Ag)-antibody (Ab) aggregates prepared with several different anti- 
gens are solubilized by fresh serum at 37°C (complex-release activity of serum or 
CRA).  The  rate  of solubilization  varies  in  different  systems  and  is  strongly 
influenced by the affinity of Ab for the Ag in the immune precipitate.  With a 
given Ag-Ab precipitate,  the maximum amount of complex that can be solubi- 
lized by individual sera is independent of the initial concentration of complexes 
and cannot be increased by prolonged incubation.  CRA occurs in the absence of 
C2 and C4, but not in the absence of C3 and factor B of the properdin pathway. 
Addition of C2 to C2-deficient serum or C4 to C4-deficient serum enhances CRA. 
Solubilization  does not involve extensive  degradation  of the  complexed  anti- 
body, as might be detected by acrylamide gel electrophoresis of released anti- 
body  after  reduction  and  alkylation  to  separate  H  and  L  chains.  Immune 
precipitates  can also be solubilized by incubation  with monovalent fragments 
(Fab or Fab')  of antibodies  against  determinants  of the  Ab molecules in  the 
immune precipitate. In contrast, F(ab')2 fragments decrease the solubility of the JOYCE  CZOP AND  VICTOR NUSSENZWEIG  629 
immune  precipitates.  In view of these  findings,  we  propose that  CRA  is  me- 
diated by the binding of functionally monovalent C fragments (C3 and C4) onto 
Ab molecules in the precipitates. 
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